Endoscopically guided laser catheter receives FDA premarket approval for treating atrial fibrillation

CardioFocus (Marlborough, MA) has received FDA premarket approval (PMA) for its HeartLight endoscopic laser ablation system for treating patients with paroxysmal atrial fibrillation (AF; the most common cardiac arrhythmia). The approved PMA submission contained comprehensive safety and effectiveness data from the company's multi-center HeartLight U.S. Pivotal Clinical Study, a randomized, controlled study in which a total of 353 participants were randomized at 19 leading arrhythmia centers across the U.S.

Related: FDA accepts CardioFocus' premarket application for endoscopically guided laser catheter

Results from the trial showed that when performing a single ablation procedure using the HeartLight system, the majority of patients experienced freedom from paroxysmal AF at 12 months. In addition, both the primary safety and efficacy endpoints were met.

The HeartLight system allows an electrophysiologist to control the delivery of therapeutic laser energy under direct visual guidance, to electrically and durably isolate the pulmonary veins (PVs). The system provides maximum procedural flexibility with a highly compliant balloon that accommodates diverse PV anatomies and laser energy that the clinician delivers under direct endoscopic visualization.

The U.S. pivotal clinical study results are added to dozens of independent studies supporting the HeartLight system. Several published EU single-center studies have reported high rates up to 80% of freedom from AF recurrence measured one year or more after the performance of a single ablation procedure. To date, more than 3400 patients worldwide have been treated using the system.

The company is finalizing preparations to commercialize the system in the U.S.

For more information, please visit www.cardiofocus.com.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.

Low-level laser therapy could speed muscle recovery at Rio 2016 Olympics

The gold medal-winning women’s U.S. Gymnastics team is reportedly experimenting with infrared light therapy to alleviate pain and reduce swelling in its athletes. (Update: A spokesperson for ...

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World